Connection

Dimitrios Farmakiotis to Voriconazole

Back to Details
This is a "connection" page, showing publications Dimitrios Farmakiotis has written about Voriconazole.
Dimitrios Farmakiotis
Connection Strength
0.623
Voriconazole
  1. Prolonged voriconazole treatment in a patient with chronic lymphocytic leukemia resulting in a litany of chronic overlapping toxicities. J Oncol Pharm Pract. 2019 Apr; 25(3):747-753.
    View in: PubMed
    Score: 0.315
  2. Persistent CNS toxicity in a patient receiving posaconazole tablets after discontinuation of voriconazole due to supratherapeutic serum levels. J Antimicrob Chemother. 2018 01 01; 73(1):256-258.
    View in: PubMed
    Score: 0.155
  3. Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial. J Antimicrob Chemother. 2018 03 01; 73(3):757-763.
    View in: PubMed
    Score: 0.078
  4. Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015. Clin Infect Dis. 2017 Jul 15; 65(2):216-225.
    View in: PubMed
    Score: 0.075
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.